Friday, January 4, 2013

• SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Other EventsEDGAR Online (Fri, Jan 4)

Thursday, January 3, 2013

• Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Biotech ShowcaseTM 2013 ConferenceBusiness Wire (Thu, Jan 3)

Wednesday, December 19, 2012

• SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online (Wed, Dec 19)

Thursday, December 13, 2012

• Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate IncreasesMarketwired (Thu, Dec 13)

Wednesday, December 12, 2012

• Lilly Forgoes FDA Filing, Sucampo Wins FDA sNDA Approval: Healthcare Business Recapat Wall St. Cheat Sheet (Wed, Dec 12)
• 2 Biotech Stocks I'm Considering Todayat Seeking Alpha (Wed, Dec 12)
• Sucampo gets approval for glaucoma drug ResculaAP (Wed, Dec 12)
• Sucampo Pharmaceuticals wins FDA approval for glaucoma treatmentat bizjournals.com (Wed, Dec 12)
• FDA move boosts Sucampo PharmaoptionMONSTER (Wed, Dec 12)
• Sucampo Announces FDA Approval of an sNDA for RESCULA® (unoprostone isopropyl)Business Wire (Wed, Dec 12)

Tuesday, December 11, 2012

• Japanese Amitiza Launch Provides Immediate Upside For Sucampo Pharmaceuticalsat Seeking Alpha (Tue, Dec 11)
• Sucampo Receives $15 Million Milestone Payment from Abbott on First Sale of AMITIZA® (lubiprostone) in JapanBusiness Wire (Tue, Dec 11)

Tuesday, December 4, 2012

• Geron Moves Up, Sucampo Wins FDA Approval to Discontinue Warnings: Health Care Business Updateat Wall St. Cheat Sheet (Tue, Dec 4)

Monday, December 3, 2012

• Sucampo Drops After FDA Delays Amitiza Decisionat Bloomberg (Mon, Dec 3)
• SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and ExEDGAR Online (Mon, Dec 3)

Friday, November 30, 2012

• Sucampo falls as FDA extends Amitiza reviewAP (Fri, Nov 30)
• Sucampo Announces Approval of a Supplemental Application for Updates to AMITIZA (lubiprostone) Pregnancy LabelingBusiness Wire (Fri, Nov 30)

Tuesday, November 27, 2012

• SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other EventsEDGAR Online (Tue, Nov 27)

Monday, November 26, 2012

• Sucampo & Abbott’s Drug in Japan, J&N’s TB Medication: Healthcare Biz Reportat Wall St. Cheat Sheet (Mon, Nov 26)
• Sucampo and Abbott Announce Launch of AMITIZA in JapanBusiness Wire (Mon, Nov 26)

Wednesday, November 14, 2012

• CORRECTING and REPLACING Sucampo Pharmaceuticals Announces Webcast of its Presentation at the 2012 Credit Suisse Healthcare ConferenceBusiness Wire (Wed, Nov 14)
• SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online (Wed, Nov 14)

Friday, November 9, 2012

• SUCAMPO PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Fri, Nov 9)

Thursday, November 8, 2012

• SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD DiscloEDGAR Online (Thu, Nov 8)
• Sucampo Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2012 Financial and Operating ResultsBusiness Wire (Thu, Nov 8)

Add SCMP News to My Yahoo!